Msheireb Museums and Sidra Medicine host Science Café on AI in Precision Medicine
The Science Café session examined cutting-edge developments in AI-assisted medicine, including machine learning applications in diagnostics, personalised treatment protocols, and the ethical considerations of implementing AI in healthcare settings. Discussions highlighted Qatar's pioneering efforts in integrating AI technologies with genomic medicine and digital health solutions.
Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine, said: "Qatar's investment in AI-driven precision medicine positions the country as an early adopter of global healthcare innovation. Through our ongoing efforts with disease cohorts and our collaborative research networks, Sidra Medicine is building comprehensive datasets that, when combined with AI, unlock unprecedented insights into disease mechanisms and treatment responses. This Science Café session demonstrated how these technologies are already improving patient care and will continue to transform precision medicine in the years ahead."
Abdulla Al Naama, General Manager of Msheireb Museums, said: "Science Café continues to serve as a vital bridge between scientific innovation and public understanding. By hosting discussions on transformative technologies like AI in medicine, Msheireb Museums fulfils its mission of fostering dialogue about progress while maintaining our connection to humanity. These conversations are essential for ensuring that technological advancement serves the broader community."
The session featured speakers and a panel session with Dr. Muneera Al-Qahtani, Senior Research Associate from Qatar Environment and Energy Research Institute; Dr. Mitch Stotland, Vice Chair of Surgery and Founder of the AI and Medicine Conference series at Sidra Medicine; Dr. Madeeha Kamal, Acting Division Chief of Adolescent Medicine at Sidra Medicine; Dr. Amr Metwally, Asst. Executive Director at Hamad Medical Corporation's Itqan Clinical Simulation and Innovation Center; and Dr. Yosra Mekki a recent graduate from Qatar University's College of Medicine.
Dr Sahar Da'as, Research Manager at Sidra Medicine and founder of the Science Café series, said: "The integration of AI in precision medicine represents a paradigm shift in how we approach precision medicine and healthcare. At Sidra Medicine, we are witnessing firsthand how machine learning algorithms can analyse vast genomic datasets to predict disease patterns, optimise treatment pathways, and deliver truly personalised care. This session showcased Qatar's leadership in harnessing AI to revolutionise patient care and outcomes."
Exhibitors from Vraxa, Biotech Medical, Avey and SaVest, specialising in AI, virtual reality and advanced medical technologies, were also present to showcase the latest advancements in the application of AI in healthcare and precision medicine.
The 2025 Science Café series continues to align with Qatar Foundation's mission to advance knowledge and community awareness. The series provides a platform for public engagement with cutting-edge scientific developments, fostering dialogue between researchers, clinicians, and the community.
About Msheireb Properties
Msheireb Properties, backed by Qatar Foundation and Qatar Investment Authority, is Qatar's leading sustainable real estate developer. The company has pioneered sustainable urban development in Qatar, supporting the goals of Qatar's 2030 Vision.
Its mission is to change how people think about urban living and improve their overall quality of life through innovations that encourage social interaction, respect for culture, and greater care for the environment.
The signature Msheireb Downtown Doha development is one of the smartest, most sustainable city districts globally. It employs a new approach to urban planning by combining traditional methods and modern technology to preserve Qatar's environment and cultural identity. All buildings are either Gold or Platinum LEED-certified.
Msheireb Downtown Doha is an integrated city that embraces modern, fully furnished residential units, a range of mixed-use and commercial buildings that offer a wide array of retail and business services, and cultural facilities. It is also the home to Msheireb Museums, Mandarin Oriental Hotel, Al Wadi Hotel - MGallery by AccorHotels, Park Hyatt Hotel, Msheireb Galleria, and Barahat Msheireb - the biggest open-air covered pedestrian square in the region.
The company also developed Zulal Wellness Resort by Chiva-Som, the Middle East's first and largest wellness destination. Located in northern Qatar, the resort offers two distinct experiences: Zulal Serenity, a wellness haven for individuals and couples, and Zulal Discovery, a world-first wellness offering for families. The resort is pioneering in its integration of Traditional Arabic and Islamic Medicine (TAIM) with contemporary wellness practices.
About Sidra Medicine
Innovating Care. Transforming Lives
From the heart of Qatar, Sidra Medicine, is a private, not-for-profit academic healthcare and research institution for women, children, and young people.
Established by the Qatar Foundation for Education, Science, and Community Development, Sidra Medicine is committed to delivering exceptional patient and family-focused care, conducting innovative biomedical and clinical research, and providing a personalized journey of care and cure and precision medicine specifically for rare and genetic diseases.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
36 minutes ago
- Zawya
Dubai Municipality conducts 34,700 food inspections in the first half of 2025, supporting rapid sector growth
173,775 food shipments cleared through ports, totalling 4.9 million tons. 940,000 food items inspected and cleared; 77,700 new food products registered. Dubai, United Arab Emirates: Dubai Municipality has announced significant achievements in food safety and inspection efforts during the first half of 2025, conducting 34,700 inspection visits across food establishments throughout the emirate. These inspections ensured compliance with approved health regulations and safety standards, reaffirming the Municipality's pivotal role in protecting public health and ensuring the availability of safe, high-quality food in Dubai. These efforts form part of the Municipality's broader mission to build an integrated and sustainable food system that improves quality of life for residents and visitors alike, while supporting Dubai's vision of becoming one of the most liveable and future-ready cities in the world. The first half of 2025 also saw exceptional growth in the food sector, with the opening of approximately 2,336 new food establishments. This expansion reinforces Dubai's reputation as a leading destination for investment in the food and hospitality industries. At the same time, around 173,775 food shipments — totalling 4.9 million tons — were cleared through Dubai's ports, strengthening the city's strategic role as a global food trade gateway. In addition to these milestones, Dubai Municipality cleared approximately 940,000 food items following rigorous inspections and registered around 77,700 new food products in its approved databases. These figures reflect the efficiency of the Municipality's digital food registration and inspection systems, which are aligned with international best practices and evolving safety protocols. Commenting on the achievements, Dr Sultan Al Taher, Director of the Food Safety Department at Dubai Municipality, said: 'Safeguarding food safety is a cornerstone of enhancing quality of life in the emirate. These achievements reflect the ongoing efforts by Dubai Municipality to build a comprehensive and sustainable food ecosystem that promotes well-being and consumer trust in the quality of food available in our markets. We remain committed to enforcing the highest food safety standards and establishing a benchmark model that reinforces Dubai's regional and global leadership in food safety oversight.' Dubai Municipality continues to enhance its regulatory oversight by integrating smart tools and advanced technologies to ensure food integrity across the supply chain. These initiatives are essential in keeping pace with Dubai's rapid economic and trade growth and reaffirm the city's position as a global centre that prioritises the health, safety, and happiness of its communities. For Media Inquiries, Please Contact: Hassane Ghanem Hghanem@ Nada Aref Naref@ DubaiMunicipality@
Zawya
2 hours ago
- Zawya
Emirates Post issues commemorative stamp, marking Supreme Council for Motherhood and Childhood's 20th anniversary
United Arab Emirates: Emirates Post, in collaboration with the Supreme Council for Motherhood and Childhood, issued a commemorative stamp to celebrate the 20th anniversary of the Council's foundation, celebrating its profound contributions to UAE society. The stamp commemorates the Council's journey since its establishment in 2003 by the late Sheikh Zayed bin Sultan Al Nahyan, whose visionary leadership laid the foundation for the UAE's progress. It also underscores the Council's pivotal role over the past two decades in championing the rights and welfare of mothers and children, under the leadership of H.H. Sheikha Fatima bint Mubarak, Chairwoman of the General Women's Union, President of the Supreme Council for Motherhood and Childhood, and Supreme Chairwoman of the Family Development Foundation, Mother of the Nation. This commemorative issue highlights the Council's unwavering efforts to enhance maternal and child welfare across the UAE, reinforcing its role as the official national body entrusted with addressing issues related to motherhood and childhood. The Council remains a foundational institution within the UAE's social framework, dedicated to safeguarding the well-being of mothers and children. H.E. Rym Abdullah Al Falasy, Secretary-General of the Supreme Council for Motherhood & Childhood, emphasised that the Council's accomplishments over its 20-year journey are largely attributed to the steadfast support and vision of H.H. Sheikha Fatima bint Mubarak. Her Highness's leadership has significantly advanced the maternal and childhood sector, aligning it with the aspirations of UAE mothers and the hopes of their children. H.E. Al Falasy noted that Her Highness has been the Council's strongest advocate, closely overseeing its progress and cultivating a nurturing environment that has yielded substantial benefits for mothers and children nationwide. H.E. added: 'These efforts have translated into world-class opportunities, services, and capabilities, surpassing the standards of the most advanced nations. As a result, mothers and children have become central to the UAE's sustainable development and active contributors to its promising future.' H.E. further remarked that the commemorative stamp serves as a tribute to two decades of dedicated service and unwavering commitment to empowering two of the nation's most cherished segments. It also reflects the Council's initiatives that align with the UAE leadership's vision of placing people at the core of national priorities, enhancing well-being, ensuring happiness, and improving quality of life. Tariq Al Wahedi, Group CEO of 7X, said: 'This commemorative stamp reflects the dedication of Emirates Post to preserving the UAE's rich cultural legacy and honouring its outstanding achievements. Postal stamps have long served as faithful chronicles of the nation's evolution, capturing milestones, progress, and values for future generations. This collaboration with the Supreme Council for Motherhood and Childhood celebrates its vital role in empowering mothers and children, reinforcing the UAE's global reputation as a beacon of social welfare and sustainable development.' The stamp design features the date July 30, the day the official decree establishing the Supreme Council for Motherhood and Childhood was published in the UAE's Official Gazette in 2003, alongside an image of the Council's newly inaugurated headquarters bearing its official name. The headquarters' distinctive architecture stands as a symbol of the Council's progress and enduring legacy. It represents the Council's trailblazing initiatives to elevate social welfare for mothers and children, while fostering a culture of innovation and creativity that enables both to thrive and actively shape their communities, driven by a bold vision for a society rooted in well-being and happiness. -Ends-
Zawya
3 hours ago
- Zawya
New agreement brings breakthrough dyslipidemia treatment to Saudi Arabia and MEA
JEDDAH – Jamjoom Pharma, a leading Saudi pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products across MEA, and Althera Laboratories, a company dedicated to developing and commercializing innovative therapies for cardiovascular and metabolic diseases, today announced a strategic licensing and supply agreement. This agreement is poised to address the growing need for effective dyslipidemia management in the region, contributing to better patient outcomes and cardiovascular health. Under this agreement, Jamjoom Pharma gets exclusive rights to commercialize in Saudi Arabia and non-exclusive rights for phased expansion across other MEA markets for Althera's fixed-dose combination of dual-action cholesterol-lowering therapy. The product launch in Saudi Arabia is targeted for 2027, with plans for phased expansion across MEA markets, subject to local regulatory approvals. This collaboration marks a major milestone for both companies: Jamjoom strengthens its cardiovascular portfolio with a globally recognized and clinically effective therapy, while Althera expands its international footprint in a high-growth region. The partnership aims to address the region's growing burden of cardiovascular diseases by increasing access to modern, affordable lipid-lowering treatment, to support patients across MEA. Dr. Tarek Hosni, CEO of Jamjoom Pharma, highlighted that: 'Cardiovascular diseases remain to be a leading health concern in Saudi Arabia and the wider MEA region, and this partnership enables us to provide patients across the MEA region with an innovative, evidence-based solution. Expanding access to effective cholesterol management aligns perfectly with our promise to deliver high-quality, affordable medications that improve lives.' Sanjeev Agarwal, CEO of Althera added " This partnership with Jamjoom Pharma is a pivotal step for Althera, allowing us to extend our reach into the rapidly growing MENA region. We are confident that Jamjoom's deep market understanding and robust capabilities make them the perfect partner to deliver our Rproduct to healthcare providers and patients in Saudi Arabia and across MENA. This collaboration is a testament to our dedication to making innovative and affordable cardiovascular treatments more accessible globally." About Althera: Founded in 2010, Althera focuses on developing, out-licensing, manufacturing and supplying high value branded and select complex generic medicines. Althera pioneers innovative value added combinations fostering benefits throughout the value chain resulting in benefits for our partners, payers, prescribers and patients particularly in heart disease, diabetes and obesity management. Althera is headquartered in Dublin, Ireland. About Jamjoom Pharma 'Jamjoom Pharmaceuticals Factory Company': Jamjoom Pharma is a leading pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products. Headquartered in Saudi Arabia, the company was established back in 2000 and is tirelessly operating to support the Saudi Vision 2030 to reinforce the public healthcare system. With a strong focus on patient-centered care, Jamjoom Pharma serves diverse markets across Middle East & Africa, with a bold ambition for more expansion, providing effective solutions in key therapeutic areas (including ophthalmology, dermatology, cardiometabolic, gastrointestinal, and general medicine). Through its state-of-the-art facilities and established distribution channels across the MEA region and dedication to regulatory excellence, Jamjoom Pharma continues to deliver products that meet the highest standards of safety, efficacy, and quality, improving health outcomes for millions of people.
